This report discusses US ethical pharmaceuticals for the years 2005 and 2010, with forecasts for 2015. Topics covered include pharmaceutical market size, regulatory and patent status, pharmaceutical segmentation, health care funding, regulatory considerations, market environment, regulatory and patebt status forecasts, product forecasts, industry composition and leading participants. Product segments cover hormones and related agents, central nervous system (CNS) agents, hormones and related agents, cardiovascular agents, biologics, anti-infective agents, respiratory agents, and other agents. Pharmaceutical demand by regulatory status (ethical and over-the-counter [OTC]) and commercial status (proprietary and generic) is also included. This 20 page report also includes a highlights summary and a resources section.